To support the importance of T-cell immunity in controlling tumour progression, it must be anticipated that one of the well-characterized mechanisms of cancer immune evasion is to hijack CD8+ T-cell responses basically through the down-regulation of major histocompatibility complex (MHC) class I and the interference with antigen processing pathway in tumour cells [13]. Here, CD8A is linked to neoplasm.